Novartis Recalls Lamisil AT Cream Due to Illegible Labeling
Novartis Consumer Health is recalling specific lots of Lamisil AT Cream because the lot and expiration dates on the tubes may be illegible.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which indicates the product is not likely to cause adverse health consequences. The hazard is limited to packaging/labeling legibility issues.
Plain-English summary
Novartis Consumer Health is voluntarily recalling 41,400 boxes of Lamisil AT Cream (terbinafine hydrochloride 1% antifungal). The recall involves 12 gm and 30 gm tubes packaged in one box (Club Pack) with NDC 0067-6295-43. The affected products are identified by Lot numbers 10109590 and 10111050, with an expiration date of 2/28/13.
The recall was initiated because the lot and/or expiration date on the tube may not be legible for these specific lots. This labeling issue could prevent consumers from verifying the product's identity and expiration status.
The affected products were distributed nationwide, in Puerto Rico, and in Panama, including military distribution. Consumers who have these specific lots should stop using the product and contact Novartis Consumer Health for a refund or replacement.
The recalled product
- Product
- Lamisil AT Cream (terbinafine hydrochloride 1% antifungal), 12 gm ( .42 oz) Tubes and 30 gm (1 oz) Tubes packaged in one box, Novartis Consumer Health, Inc., Parsitan, NJ. UPC code: 300676249438. (Club Pack), NDC 0067-6295-43
- Manufacturer
- Novartis Consumer Health
- Category
- Drug — Topical Antifungal
- Hazard
- Affected units
- 41,400
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot #: 10109590
- 10111050
- Exp 2/28/13.
Distribution
Part of a larger recall action
This product is one of 5 recalled by Novartis Consumer Health under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same manufacturer · Novartis Consumer Health
See all →- ModerateNovartis Recalls Benefiber Fiber Supplement Stick Packs Due to Consumer Complaints
FDA (Food) · 2014-03-05
- ModerateNovartis Recalls Theraflu Severe Cold & Cough Powder Packets for Foreign Substances
FDA (Drugs) · 2014-01-29
- HighNovartis Recalls Theraflu Powder Packets Due to Foreign Substance Presence
FDA (Drugs) · 2014-01-29
- ModerateNovartis Recalls NeoCitran Extra Strength Powder Packets Due to Foreign Substances
FDA (Drugs) · 2014-01-29
- ModerateNovartis Recalls Theraflu Exte Powder Packets Due to Foreign Substances
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- HighByron White A-L Complex Herbal Supplement Recalled for Undeclared Walnut
FDA (Food) · 2026-09-02
- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02